ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: As discussed above, the 10-year CML-specific survival could be as high as 90% among patient with BCR::ABL1 transcripts (IS) 1–10%, and 75% with transcripts >10% [46].